Kate H. Rademacher
Kate H. Rademacher is a Technical Advisor in FHI 360’s Contraceptive Technology Innovation department where she supports the development and introduction of new, long-acting contraceptives for low-resource settings. She has fifteen years of experience in family planning program design and management.
Rademacher serves as the technical lead for a portfolio of work to evaluate the potential impact of the levonorgestrel intrauterine system (LNG-IUS) in several countries in sub-Saharan Africa. She works with multi-disciplinary teams that have conducted or are conducting market assessments in Kenya, Zambia and Nigeria, and she led an analysis that compared the direct service delivery costs of the LNG-IUS to other family planning methods.
Rademacher also serves as the strategic partnership manager for the Gates-funded Contraceptive Technology Innovation Initiative and Sino-implant (II) project and the USAID-funded Envision FP project. In this role, she engages a variety of partners including research organizations, pharmaceutical companies, policymakers, non-governmental organizations and service delivery groups to achieve project objectives and to help ensure affordable access to new contraceptive products that are under development or are currently being introduced.
Previously, Rademacher worked for five years on the Research Utilization team at FHI 360 where she helped accelerate the translation of research findings into policy and practice. She has a Masters of Healthcare Administration from the Gillings School of Global Public Health at the University of North Carolina at Chapel Hill, and an undergraduate degree in Sociology from Wesleyan University.